Found: 4
Select item for more details and to access through your institution.
Real‐world analysis of main clinical outcomes in patients with polycythemia vera treated with ruxolitinib or best available therapy after developing resistance/intolerance to hydroxyurea.
- Published in:
- Cancer (0008543X), 2022, v. 128, n. 13, p. 2441, doi. 10.1002/cncr.34195
- By:
- Publication type:
- Article
Cytoreductive treatment in patients with CALR‐mutated essential thrombocythaemia: a study comparing indications and efficacy among genotypes from the Spanish Registry of Essential Thrombocythaemia.
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 6, p. 988, doi. 10.1111/bjh.16988
- By:
- Publication type:
- Article
Frequency and prognostic value of resistance/intolerance to hydroxycarbamide in 890 patients with polycythaemia vera.
- Published in:
- British Journal of Haematology, 2016, v. 172, n. 5, p. 786, doi. 10.1111/bjh.13886
- By:
- Publication type:
- Article
Natural history of polycythemia vera and essential thrombocythemia presenting with splanchnic vein thrombosis.
- Published in:
- 2020
- By:
- Publication type:
- journal article